189 related articles for article (PubMed ID: 35169199)
1. A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer.
Fong LWR; Lee J; Lin HK; Ueno NT; Zhang S
Sci Rep; 2022 Feb; 12(1):2478. PubMed ID: 35169199
[TBL] [Abstract][Full Text] [Related]
2. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates.
Zhang F; Zhao Y; Sun Y
J Biol Chem; 2021 Oct; 297(4):101109. PubMed ID: 34425107
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
[TBL] [Abstract][Full Text] [Related]
4. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
5. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
6. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation.
Yuan J; Zhu Z; Zhang P; Ashrafizadeh M; Abd El-Aty AM; Hacımüftüoğlu A; Linnebacher CS; Linnebacher M; Sethi G; Gong P; Zhang X
Cancer Lett; 2024 Apr; 587():216733. PubMed ID: 38360141
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
[TBL] [Abstract][Full Text] [Related]
8. USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells.
Xia X; Liu X; Chai R; Xu Q; Luo Z; Gu J; Jin Y; Hu T; Yu C; Du B; Huang H; Ou W; Liu S; Liu N
J Biol Chem; 2021 Nov; 297(5):101258. PubMed ID: 34599966
[TBL] [Abstract][Full Text] [Related]
9. The role of ubiquitination and deubiquitination in tumor invasion and metastasis.
Han S; Wang R; Zhang Y; Li X; Gan Y; Gao F; Rong P; Wang W; Li W
Int J Biol Sci; 2022; 18(6):2292-2303. PubMed ID: 35414786
[TBL] [Abstract][Full Text] [Related]
10. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.
Yu X; Zhou L; Liu W; Liu L; Gao F; Li W; Liu H
Cell Death Dis; 2022 Mar; 13(3):249. PubMed ID: 35301297
[TBL] [Abstract][Full Text] [Related]
11. Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis.
Xu D; Li CF; Zhang X; Gong Z; Chan CH; Lee SW; Jin G; Rezaeian AH; Han F; Wang J; Yang WL; Feng ZZ; Chen W; Wu CY; Wang YJ; Chow LP; Zhu XF; Zeng YX; Lin HK
Nat Commun; 2015 Mar; 6():6641. PubMed ID: 25818643
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
14. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
Fujita T; Liu W; Doihara H; Date H; Wan Y
Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
[TBL] [Abstract][Full Text] [Related]
15. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
16. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
[TBL] [Abstract][Full Text] [Related]
17. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
18. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Tokarz S; Berset C; La Rue J; Friedman K; Nakayama K; Nakayama K; Zhang DE; Lanker S
J Biol Chem; 2004 Nov; 279(45):46424-30. PubMed ID: 15342634
[TBL] [Abstract][Full Text] [Related]
19. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
Breast Cancer Res; 2006; 8(4):R46. PubMed ID: 16859513
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
